Drug Type Small molecule drug |
Synonyms repurposed imipramine(Ennaid Therapeutics) |
Target |
Action modulators |
Mechanism fascin modulators(fascin actin-bundling protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | United States | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | European Union | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | European Union | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | Japan | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | Australia | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | Canada | 26 Mar 2021 |